SkyePharma to Present at The Banc of America Securities Specialty Pharamceuticals Conference LONDON, July 22 /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKPLSE: Nasdaq:LSE:SKYE) announces today that the Company's Chief Executive Officer, Michael Ashton, will make a presentation during a panel discussion on the Drug Delivery Industry at the Banc of America Securities Specialty Pharmaceuticals Conference on Thursday, July 29th, 2004 at 2.15 p.m. (EST) in New York. Investors may access a live webcast of the presentation at http://www.skyepharma.com/ under the Investor Relations tab. For the slides of this presentation, please visit SkyePharma's website http://www.skyepharma.com/ under Investor Relations / Presentations. About SkyePharma SkyePharma develops pharmaceutical products benefiting from world-leading drug delivery technologies that provide easier-to-use and more effective drug formulations. There are now ten approved products incorporating SkyePharma's technologies in the areas of oral, injectable, inhaled and topical delivery, supported by advanced solubilisation capabilities. For more information, visit http://www.skyepharma.com/. For further information please contact: SkyePharma PLC +44 207 491 1777 Michael Ashton, Chief Executive Officer Peter Laing, Director of Corporate Communications +44 207 491 5124 Sandra Haughton, US Investor Relations +1 212 753 5780 Buchanan Communications +44 207 466 5000 Tim Anderson / Mark Court DATASOURCE: SkyePharma PLC CONTACT: Michael Ashton, Chief Executive Officer, +44-207-491-1777, or Peter Laing, Director of Corporate Communications, +44-207-491-5124, or Sandra Haughton, US Investor Relations, +1-212-753-5780, all of SkyePharma PLC; Tim Anderson or Mark Court, both of Buchanan Communications,+44-207-466-5000, for SkyePharma PLC Web site: http://www.skyepharma.com/

Copyright